Basic Information
RNALocate ID: RLID-D:11000271
RNA Symbol: hsa-miR-18a-5p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-18a-5p
RNA ID: miRBase:MIMAT0000072
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
Tissue/Cell Line: Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
Database: EVmiRNA
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11000707 Exosome Breast milk 22211110
RLID:11000708 Exosome Brain tissue 23382797
RLID:11000709 Exosome Plasma 23663360
RLID-D:11001156 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-18a-5p Splenic marginal zone lymphoma MNDR-E-MI-21718
MNDR hsa-miR-18a-5p Multiple sclerosis chronic progressive MNDR-E-MI-21719
MNDR hsa-miR-18a-5p Oral squamous cell carcinoma MNDR-E-MI-21720
MNDR hsa-miR-18a-5p Large cell neuroendocrine cancer MNDR-E-MI-21721
MNDR hsa-miR-18a-5p Follicular cleaved lymphoma MNDR-E-MI-21722
MNDR hsa-miR-18a-5p Medulloblastoma MNDR-E-MI-21723
MNDR hsa-miR-18a-5p Small intestinal neuroendocrine tumor MNDR-E-MI-21724
MNDR hsa-miR-18a-5p High-grade serous ovarian carcinoma MNDR-E-MI-21725
MNDR hsa-miR-18a-5p Ovarian clear cell carcinoma MNDR-E-MI-21726
MNDR hsa-miR-18a-5p Uterine corpus endometrial carcinoma MNDR-E-MI-21727
MNDR hsa-miR-18a-5p Autism spectrum disorder MNDR-E-MI-21728
MNDR hsa-miR-18a-5p Lymphoma MNDR-E-MI-21729
MNDR hsa-miR-18a-5p Lymphoma non-hodgkin MNDR-E-MI-21730
MNDR hsa-miR-18a-5p Estrogen-receptor positive breast cancer MNDR-E-MI-21731
MNDR hsa-miR-18a-5p Estrogen-receptor negative breast cancer MNDR-E-MI-21732
MNDR hsa-miR-18a-5p Progesterone-receptor positive breast cancer MNDR-E-MI-21733
MNDR hsa-miR-18a-5p Progesterone-receptor negative breast cancer MNDR-E-MI-21734
MNDR hsa-miR-18a-5p Her2-receptor positive breast cancer MNDR-E-MI-21735
MNDR hsa-miR-18a-5p Triple negative breast cancer MNDR-E-MI-21736
MNDR hsa-miR-18a-5p Breast cancer luminal MNDR-E-MI-21737
MNDR hsa-miR-18a-5p Thyroid carcinoma anaplastic MNDR-E-MI-21738
MNDR hsa-miR-18a-5p Small intestine cancer MNDR-E-MI-21739
MNDR hsa-miR-18a-5p Dermatomyositis MNDR-E-MI-21740
MNDR hsa-miR-18a-5p Prostate cancer MNDR-E-MI-21741
MNDR hsa-miR-18a-5p Gastric cancer MNDR-E-MI-21742
MNDR hsa-miR-18a-5p Gastric lymphoma MNDR-E-MI-21743
MNDR hsa-miR-18a-5p Alzheimer disease MNDR-E-MI-21744
MNDR hsa-miR-18a-5p Intracranial aneurysm MNDR-E-MI-21745
MNDR hsa-miR-18a-5p Bladder cancer MNDR-E-MI-21746
MNDR hsa-miR-18a-5p Esophageal carcinoma MNDR-E-MI-21747
MNDR hsa-miR-18a-5p Sarcoma MNDR-E-MI-21748
MNDR hsa-miR-18a-5p Dysautonomia familial MNDR-E-MI-21749
MNDR hsa-miR-18a-5p Head and neck cancer MNDR-E-MI-21750
MNDR hsa-miR-18a-5p Leukemia MNDR-E-MI-21751
MNDR hsa-miR-18a-5p Cardiovascular disease MNDR-E-MI-21752
MNDR hsa-miR-18a-5p Carotid stenosis MNDR-E-MI-21753
MNDR hsa-miR-18a-5p Lung cancer MNDR-E-MI-21754
MNDR hsa-miR-18a-5p Parkinson disease MNDR-E-MI-21755
MNDR hsa-miR-18a-5p Machado-joseph disease MNDR-E-MI-21756
MNDR hsa-miR-18a-5p Basal-like breast cancer MNDR-E-MI-21757
MNDR hsa-miR-18a-5p Thyroid cancer MNDR-E-MI-21758
MNDR hsa-miR-18a-5p Pituitary neoplasms MNDR-E-MI-21759
MNDR hsa-miR-18a-5p Pancreatic cancer MNDR-E-MI-21760
MNDR hsa-miR-18a-5p Melanoma MNDR-E-MI-21761
MNDR hsa-miR-18a-5p Rectum adenocarcinoma MNDR-E-MI-21762
MNDR hsa-miR-18a-5p Nephroblastoma MNDR-E-MI-21763
MNDR hsa-miR-18a-5p Colon cancer MNDR-E-MI-21764
MNDR hsa-miR-18a-5p Colon adenocarcinoma MNDR-E-MI-21765
MNDR hsa-miR-18a-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-21766
MNDR hsa-miR-18a-5p Familial ovarian cancer MNDR-E-MI-21767
MNDR hsa-miR-18a-5p Prostate adenocarcinoma MNDR-E-MI-21768
MNDR hsa-miR-18a-5p Kidney cancer MNDR-E-MI-21769
MNDR hsa-miR-18a-5p Carcinoma ductal breast MNDR-E-MI-21770
MNDR hsa-miR-18a-5p Glioblastoma MNDR-E-MI-21771
MNDR hsa-miR-18a-5p Astrocytoma MNDR-E-MI-21772
MNDR hsa-miR-18a-5p Glioma MNDR-E-MI-21773
MNDR hsa-miR-18a-5p Amyotrophic lateral sclerosis MNDR-E-MI-21774
MNDR hsa-miR-18a-5p Osteosarcoma MNDR-E-MI-21775
MNDR hsa-miR-18a-5p Liposarcoma MNDR-E-MI-21776
MNDR hsa-miR-18a-5p Coronary artery disease MNDR-E-MI-21777
MNDR hsa-miR-18a-5p Pancreatic ductal adenocarcinoma MNDR-E-MI-21778
MNDR hsa-miR-18a-5p Infarction middle cerebral artery MNDR-E-MI-21779
MNDR hsa-miR-18a-5p Meningioma MNDR-E-MI-21780
MNDR hsa-miR-18a-5p Uterine cancer MNDR-E-MI-21781
MNDR hsa-miR-18a-5p Cervical adenocarcinoma MNDR-E-MI-21782
MNDR hsa-miR-18a-5p Gastric adenocarcinoma MNDR-E-MI-21783
MNDR hsa-miR-18a-5p Cervical squamous cell carcinoma MNDR-E-MI-21784
MNDR hsa-miR-18a-5p Pituitary adenoma MNDR-E-MI-21785
MNDR hsa-miR-18a-5p Lung squamous cell carcinoma MNDR-E-MI-21786
MNDR hsa-miR-18a-5p Non-small cell lung adenocarcinoma MNDR-E-MI-21787
MNDR hsa-miR-18a-5p Lung adenocarcinoma MNDR-E-MI-21788
MNDR hsa-miR-18a-5p Thyroid carcinoma MNDR-E-MI-21789
MNDR hsa-miR-18a-5p Ovarian carcinoma MNDR-E-MI-21790
MNDR hsa-miR-18a-5p Bladder urothelial carcinoma MNDR-E-MI-21791
MNDR hsa-miR-18a-5p Pancreatic adenocarcinoma MNDR-E-MI-21792
MNDR hsa-miR-18a-5p Carcinoma renal cell MNDR-E-MI-21793
MNDR hsa-miR-18a-5p Kidney renal papillary cell carcinoma MNDR-E-MI-21794
MNDR hsa-miR-18a-5p Clear cell renal cell carcinoma MNDR-E-MI-21795
MNDR hsa-miR-18a-5p Esophageal cancer MNDR-E-MI-21796
MNDR hsa-miR-18a-5p Lung small cell carcinoma MNDR-E-MI-21797
MNDR hsa-miR-18a-5p Head and neck squamous cell carcinoma MNDR-E-MI-21798
MNDR hsa-miR-18a-5p T acute lymphoblastic leukemia MNDR-E-MI-21799
MNDR hsa-miR-18a-5p Acute t cell leukemia MNDR-E-MI-21800
MNDR hsa-miR-18a-5p Acute heart failure MNDR-E-MI-21801
MNDR hsa-miR-18a-5p Breast invasive carcinoma MNDR-E-MI-21802
MNDR hsa-miR-18a-5p Hepatocellular carcinoma MNDR-E-MI-21803
MNDR hsa-miR-18a-5p Familiar ovarian carcinoma MNDR-E-MI-21804
MNDR hsa-miR-18a-5p B-cell lymphoma MNDR-E-MI-21805
MNDR hsa-miR-18a-5p Rheumatoid arthritis MNDR-E-MI-21806
MNDR hsa-miR-18a-5p T-cell leukemia MNDR-E-MI-21807
MNDR hsa-miR-18a-5p Retinoblastoma MNDR-E-MI-21808
MNDR hsa-miR-18a-5p Neuroblastoma MNDR-E-MI-21809
MNDR hsa-miR-18a-5p Hodgkin lymphoma MNDR-E-MI-21810
MNDR hsa-miR-18a-5p Burkitt lymphoma MNDR-E-MI-21811
MNDR hsa-miR-18a-5p Tonsil cancer MNDR-E-MI-21812
MNDR hsa-miR-18a-5p Acute myelogenous leukemia MNDR-E-MI-21813
MNDR hsa-miR-18a-5p Colorectal cancer MNDR-E-MI-21814
MNDR hsa-miR-18a-5p Nasopharyngeal carcinoma MNDR-E-MI-21815
MNDR hsa-miR-18a-5p Multiple myeloma MNDR-E-MI-21816
MNDR hsa-miR-18a-5p Ependymoma MNDR-E-MI-21817
MNDR hsa-miR-18a-5p Nasopharyngeal cancer MNDR-E-MI-21818
MNDR hsa-miR-18a-5p Pseudorabies MNDR-E-MI-21819
MNDR hsa-miR-18a-5p Epstein-barr virus infections MNDR-E-MI-21820
MNDR hsa-miR-18a-5p Stroke lacunar MNDR-E-MI-21821
MNDR hsa-miR-18a-5p Breast cancer her3+ negative MNDR-E-MI-21822
MNDR hsa-miR-18a-5p Duke A MNDR-E-MI-21823
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ATM Homo sapiens RR00158089
TOP